Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Long-term efficacy of olmesartan medoxomil in Chinese hypertensive patients as assessed by clinic, ambulatory and home blood pressure measurements.

Wang JG, Sun NL, Ke YN, Zhang BH, Ikegami N, Zhu JR.

Clin Drug Investig. 2012 Nov;32(11):729-34. doi: 10.1007/s40261-012-0003-7.

2.

Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.

Malacco E, Omboni S, Mallion JM, Volpe M; ESPORT Study Group.

High Blood Press Cardiovasc Prev. 2012 Dec;19(4):213-22. doi: 10.1007/BF03297633. Epub 2013 Feb 19.

PMID:
23430666
5.

Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.

Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.

Clin Drug Investig. 2010;30(9):581-97. doi: 10.2165/11536710-000000000-00000. Erratum in: Clin Drug Investig. 2013 Jan;33(1):95.

PMID:
20593911
6.
7.

Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.

Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, Maa JF.

Ther Adv Cardiovasc Dis. 2010 Aug;4(4):209-21. doi: 10.1177/1753944710374745. Epub 2010 Jun 2.

PMID:
20519261
9.

Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.

Heagerty AM, Mallion JM.

Drugs Aging. 2009;26(1):61-76. doi: 10.2165/0002512-200926010-00005.

PMID:
19102515
10.

Using different methods to evaluate the efficacy of olmesartan medoxomil in Chinese patients with mild to moderate essential hypertension according to ambulatory blood pressure monitoring.

Jiang H, Ke YN, Sun NL, Wang JG, Hou MW, Zhu JR; Olmesartan Medoxomil Clinical Collaborative Panel of EXPO Study.

Blood Press Monit. 2012 Oct;17(5):193-7.

PMID:
22922298
11.
12.

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.

Barrios V, Escobar C, Calderon A, Böhm M.

Vasc Health Risk Manag. 2009;5:723-9. Epub 2009 Sep 7.

13.

Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.

Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.

Clin Drug Investig. 2007;27(8):545-58.

PMID:
17638395
14.

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.

Chrysant SG, Lee J, Melino M, Karki S, Heyrman R.

J Hum Hypertens. 2010 Nov;24(11):730-8. doi: 10.1038/jhh.2010.5. Epub 2010 Feb 18.

16.

Reduction of the morning blood pressure surge treated with olmesartan in Chinese patients with mild to moderate essential hypertension--a multicenter, open-label, single treatment group clinical study.

Jiao Y, Ke Y, Sun N, Wang J, Deng W, Zhu J; Olmesartan Medoxomil Clinical Collaborative Panel; EXPO Study.

Eur Rev Med Pharmacol Sci. 2012 May;16(5):653-9.

PMID:
22774407
17.

Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Barrios V, Brommer P, Haag U, Calderón A, Escobar C.

Clin Drug Investig. 2009;29(7):427-39. doi: 10.2165/00044011-200929070-00001.

PMID:
19499960
18.

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.

Chrysant SG, Marbury TC, Robinson TD.

J Hum Hypertens. 2003 Jun;17(6):425-32.

PMID:
12764406
19.

Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.

Chrysant SG, Germino FW, Neutel JM.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):375-89. doi: 10.2165/11636080-000000000-00000. Review.

PMID:
23116225
20.

Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.

White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S.

Hypertension. 2011 Mar;57(3):413-20. doi: 10.1161/HYPERTENSIONAHA.110.163402. Epub 2011 Jan 31.

Supplemental Content

Support Center